Dérivés d'hétéroaryle et phénylsulfamoyle substitués

The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use of such compounds as peroxisome proliferator activator receptor (PPAR) agonists. PPAR alpha activators, pharmaceutical compositions containing...

Full description

Saved in:
Bibliographic Details
Main Author HAMANAKA, ERNEST, SEIICHI
Format Patent
LanguageFrench
Published 01.06.2007
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use of such compounds as peroxisome proliferator activator receptor (PPAR) agonists. PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans. The compounds are also useful for the treatment of negative energy balance (NEB) and associated diseases in ruminants.
AbstractList The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use of such compounds as peroxisome proliferator activator receptor (PPAR) agonists. PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans. The compounds are also useful for the treatment of negative energy balance (NEB) and associated diseases in ruminants.
Author HAMANAKA, ERNEST, SEIICHI
Author_xml – fullname: HAMANAKA, ERNEST, SEIICHI
BookMark eNrjYmDJy89L5WSwcjm8siiz7PDKYoUU9YzDK0uA3PzEosqcVIXUEoUCoEheZU5xaU5aYm4-SLC4NKm4JLOkFKiBh4E1LTGnOJUXSnMzyLm5hjh76KYW5MenFhckJqfmpZbE-zoaWZgbGDsZGhNUAACKMTRP
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID MA28703B1
GroupedDBID EVB
ID FETCH-epo_espacenet_MA28703B13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:18 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MA28703B13
Notes Application Number: MA20060029590
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070601&DB=EPODOC&CC=MA&NR=28703B1
ParticipantIDs epo_espacenet_MA28703B1
PublicationCentury 2000
PublicationDate 20070601
PublicationDateYYYYMMDD 2007-06-01
PublicationDate_xml – month: 06
  year: 2007
  text: 20070601
  day: 01
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies PFIZER PRODUCTS INC
RelatedCompanies_xml – name: PFIZER PRODUCTS INC
Score 2.6714523
Snippet The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Dérivés d'hétéroaryle et phénylsulfamoyle substitués
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070601&DB=EPODOC&locale=&CC=MA&NR=28703B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTRNSjNIMjTTtUhKMtY1sUyz1E0ySTTVNTQ3Nk0ysEgE9sfAqy38zDxCTbwiTCOYGNJhe2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGqx3DDoLxlDNxcnWNcDfxd9ZzdnZFlh0-QXZgubzjJ2A3SRWYBvaHLT2yzXMCbQlpQC5PnETZGALABqVVyLEwJRWJMzA6Qy7dk2YgcMXOtsNZEIzXrEIg5XL4ZVFmWWHVxYrpKhnHF5ZAuTmJxZV5qQqpJYoFABF8ipziktz0hJz80GCxcDyALQIAKhBlEHOzTXE2UMX6Ih4uHfjfR2hjjUWY2DJy89LlWBQSLZISzIDtuQMk9JMgQ2glETL5MQkUPPIJM0yJSk5VZJBHIchUjhlpBm4YIvfDAxlGFhKikpTZYE1bEmSHDh0AOh-hmo
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR3LTsJAcELQiDfFB76wB4OnxjZtsTVpjPQRVFqIqYYb2S1dJcGWtEXDJ_Ed_JizDVUv3HZns5PZTea181iAK6JRJlG5LeqUKqJqMEOkKtFE-VbRqKQT9MeKbAu_3X1Vn4basALvZS1M0Sf0u2iOiBwVIr_nhbye_T1i2UVuZXZDJwhK7t3AtFuld8x7wcgtu2M6g77dt1qWZaLo8l9MHs9TOugmbaF9rfMm-85bh5ekzP7rE3cPtgeIKs73ocLSOtSs8tu1Oux462g3DteMlx3Anb1appOv1TITxtcfq2WO04Ski2kkRLkwQ0i8mGbzKSOfCQdmKA94EgBuOISm6wRWV0QiRr_HHXkPa2KVI6jGSRw1QAh1RttoycmUaWgAjYkREsrNI5UZYxpGJ3C8AcnpxpVLqHUDrzfqPfrPZ7BbJsJJ8jlU83QeXaC2zWmzuKkfXemJWg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=D%C3%A9riv%C3%A9s+d%27h%C3%A9t%C3%A9roaryle+et+ph%C3%A9nylsulfamoyle+substitu%C3%A9s&rft.inventor=HAMANAKA%2C+ERNEST%2C+SEIICHI&rft.date=2007-06-01&rft.externalDBID=B1&rft.externalDocID=MA28703B1